Peer-reviewed veterinary case report
Risk of side effects after dog vaccines with or without Leptospira
By Yao, Peng Ju et al.Ā·Published in Journal of the American Veterinary Medical AssociationĀ·2015Ā·View original on PubMed ā
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research ā every detail traces back to the citation above. How we work ā
Original publication title: Incidence rates and risk factors for owner-reported adverse events following vaccination of dogs that did or did not receive a Leptospira vaccine.
- Species:
- dog
Plain-English summary
A study involving over 130,000 dogs looked at the side effects reported by owners after their pets received vaccinations, particularly focusing on the Leptospira vaccine, which protects against a serious disease. While the overall rate of reported side effects was low, dogs receiving the Leptospira vaccine had a slightly higher chance of experiencing adverse events compared to those who did not. However, serious allergic reactions were rare and did not significantly differ between the two groups. This suggests that while there may be a small increase in mild side effects, the Leptospira vaccine is generally safe and important for preventing a potentially fatal illness.
People also search for: dog vaccination side effects Ā· Leptospira vaccine for dogs Ā· dog allergic reaction to vaccine
Abstract
OBJECTIVE: To determine incidence rates (IRs) and potential risk factors for owner-reported adverse events (AEs) following vaccination of dogs that did or did not receive a Leptospira vaccine. DESIGN: Observational, retrospective cohort study. ANIMALS: 130,557 dogs. PROCEDURES: Electronic records of mobile veterinary clinics from June 2012 to March 2013 were searched to identify dogs that received ≥ 1 vaccine in a given visit. Signalment data, vaccinations received, medications administered, and owner-reported clinical signs consistent with AEs that developed ≤ 5 days after vaccination were recorded. Associations between potential risk factors and owner-reported AEs were evaluated by logistic regression analysis. RESULTS: The IR/10,000 dogs for owner-reported postvaccination AEs was 26.3 (95% CI, 23.6 to 29.2), whereas that for dogs that received a Leptospira vaccine alone or with other vaccines was 53.0 (95% CI, 42.8 to 64.9). Significant factors for increasing or decreasing risk of AEs were as follows: receiving a Leptospira vaccine (adjusted OR, 2.13), age at vaccination 1 to < 7 or ≥ 7 years (vs a referent of < 6 months; adjusted OR, 0.54 and 0.44, respectively), and weight 13.6 to < 22.7 kg (30 to < 50 lb) and 22.7 to < 45.5 kg (50 to 100 lb [vs a referent of < 4.5 kg {10 lb}]; adjusted OR, 0.48 and 0.55, respectively). Hypersensitivity reactions were rare (IR, 6.5/10,000 dogs), and IRs for these events did not differ significantly between dogs vaccinated with or without a Leptospira component. CONCLUSIONS AND CLINICAL RELEVANCE: The overall IR for owner-reported postvaccination AEs was low. Results suggested vaccination against Leptospira (an organism that can cause fatal disease) is safe in the majority of cases, slightly increasing the risk of owner-reported AEs but not associated with a significant increase in hypersensitivity reactions, compared with other vaccinations administered.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases āOriginal publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/26517617/